Care for newborns exposed to substances during pregnancy
Official title: Clinical Care of Newborns with Prenatal Substance Exposure: A National Study
Funded at University of California at Davis · NIH-11048850 · Data updated 2026-11-12
This study is looking at how to improve hospital care for newborns who were exposed to drugs during pregnancy, like opioids and cannabis, by finding better ways to test for substances, help with withdrawal symptoms, and support families.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California at Davis NIH-funded |
| Lab location | 1 site (Davis, United States) |
| Project start | September 1, 2024 |
| Project end | June 30, 2029 |
| Funding year | 2024 |
| Award (this year) | $398,972 |
| NIH project number | 1R01HS029884-01A1 |
| Project ID | NIH-11048850 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include newborns who have been exposed to substances during pregnancy and their families.
✕Less likely to help
Patients who are not newborns or who have not been exposed to substances during pregnancy may not benefit from this research.
What this research studies
This research investigates the care practices for newborns who have been exposed to substances during pregnancy, such as opioids and cannabis. It focuses on improving hospital care by examining toxicology testing, managing withdrawal symptoms, and providing family support. The study aims to identify effective practices that can enhance the quality of care and equity for these vulnerable newborns and their families. By collaborating with the Better Outcomes through Research for Newborns (BORN) Network, the research will gather data to inform better healthcare strategies.
Why it matters
Potential benefit: If successful, this research could lead to improved healthcare practices that enhance the well-being of newborns exposed to substances and support their families.
How similar studies have gone: Previous research has shown that targeted interventions for substance-exposed newborns can lead to improved outcomes, indicating that this approach has potential for success.
Where this research is happening
-
University of California at Davis
Davis, United States Active
Researchers
- Principal investigator: Kair, Laura R — University of California at Davis
- Study coordinator: Kair, Laura R
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.